Plus   Neg

Webster Financial Reports Q4 Adj. EPS Of $0.99 - Quick Facts

Webster Financial Corp. (WBS) reported fourth quarter earnings per share of $0.64, compared to $0.96, a year ago. The company noted that earnings per share would have been $0.99 for the quarter ended December 31, 2020, adjusting for charges related to strategic optimization initiatives. On average, 12 analysts polled by Thomson Reuters expected the company to report profit per share of $0.71, for the quarter. Analysts' estimates typically exclude special items.

Fourth quarter revenue was $293.7 million; $297.4 million excluding hedge termination costs related to debt prepayments. Analysts expected revenue of $228.63 million, for the quarter. Net interest income was $216.9 million compared to $231.3 million, previous year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT